Ganaxolone for management of seizures associated with CDKL5 deficiency disorder is a research paper published in Trends in Pharmacological Sciences (2022). On theSindex it has a DataRank of 0.653. It has been cited 16 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.228
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Institute of Neurological Disorders and Stroke
Grant: R01NS100947
National Institute of Neurological Disorders and Stroke
Grant: R21NS109687
National Institute of Neurological Disorders and Stroke
Grant: R61NS124923
National Institutes of Health
Grant: 7R01NS100947-02
Inflammatory regulation of neurotrophin signaling in epileptogenesis
National Institutes of Health
Grant: 5R21NS109687-02
Targeting Prostaglandin Receptor EP2 for Glioma and Associated Epilepsy
National Institutes of Health
Grant: 1R61NS124923-01
Targeting TRPC3 Channels for Epileptic Seizures
National Institutes of Health
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals